Product Life Cycle Activities, module 9

Get an understanding of the basic regulatory requirements for a pharmaceutical product in the post-approval phase

Date icon
No available dates
Attendance icon

On location

Language icon

English

Price icon
20,200 DKK ex VAT

(app. 2,716 EUR ex VAT)

50% DISCOUNT FOR PUBLIC INSTITUTIONS

Summary

Module 9

This three day course teaches you about the regulatory possibilities and consequences of different types of life cycle activities. It also enables you to develop strategies as well as plan and perform activities related to the regulatory maintenance of a product in an everyday working environment. You will learn about the regulations and legal framework related to product life cycle management, and you will gain knowledge of and insight into regulatory requirements and opportunities in life cycle management

Our focus is on the current EU regulatory legislation and guidelines, but you will also get a brief overview of life cycle activities related to interactions with stakeholders from the safety, marketing, legal and communication fields. Throughout the course, we discuss dilemmas and decisions for regulatory professionals during the life cycle of a product.


Other course participants say

Good quality speakers, great organisation, relevant content.” 

Kristen Berger, Global Labeling Strategy Lead, Swedish Orphan Biovitrum AG


It was very comprehensive and the courses gave a lot of extra details for regulatory concepts that I know of but have not worked with.”

Audrey Systad-Wang, Regulatory Affairs Professional, Novo Nordisk A/S


    Keywords

    • The EU Variation System
    • Labeling Requirements
    • Renewals
    • Change Control Systems
    • Maintenance of the EU Product Information
    • New Indications and Extensions
    • Pediatric Regulation
    • Implementation of Pharmacovigilance Legislation
    • Implementation of Risk Management Plans and Periodic Safety Update Reports (PSURs)
    • Crisis Management
    • Referrals
    • Intellectual Properties

      Hi! 

      Do you need help choosing the right course? 

      We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com 

      Stay tuned with Atrium's newsletter 


    Save information for later
    Read more

    Course leader & lecturers

    • Christina Balslev Rindshøj
      Course leader
      VP, Head of Regulatory Affairs
      Zealand Pharma A/S
    • Dorte Bjørn-Larsen
      Course leader
      Global Regulatory Lead, RA Rare Endocrine Disorders
      Novo Nordisk A/S
    • Anna Silke Hammerbacher
      Lecturer
      Senior Director & Global Regulatory Lead
      Daiichi Sankyo
    • Sofia Persdotter
      Lecturer
      Global Regulatory Affairs CMC Lead
      Ferring Pharmaceuticals A/S
    • Mette Due Theilade Thomsen
      Lecturer
      Managing Director
      PIP Adviser
    • Mette Stie Kallesøe
      Lecturer
      Head of Pharmacovigilance QPPV
      Hansa Biopharma AB
    • Samuel David Ramsden
      Lecturer
      Head of Risk Management Office
      Boehringer Ingelheim Pharma GmbH & Co. KG
    • Lilia Nicolaeva Lisdorf
      Lecturer
      Senior Principal Regulatory Specialist
      ALK
    • Hanne Brokopp
      Lecturer
      NDA Principal Consultant
      NDA Group, Luxembourg
    • Ingrid Prieschl
      Lecturer
      Regulatory Consultant
      Zwiers Regulatory Consultancy BV
    • Lars Sparre Conrad
      Lecturer
      PhD, European Patent Attorney, Chief Patent Specialist, Corporate Patents & Trademarks
      H. Lundbeck A/S
    • Samantha Donslund Schwab
      Lecturer
      Associate Director
      Novo Nordisk A/S
    • Jacob Larsen
      Lecturer
      Scientific Director
      Novo Nordisk A/S
    See all

    Is this course for you?

    This course is for you if you are an experienced Regulatory Affairs professional, employed in the industry, a regulatory agency, or a consulting firm.

    What you will learn

    1. The basic regulatory requirements for pharmaceutical products in the post-approval phase and regulations concerning pediatrics, risk management plans, referrals and generics
    2. How and when to apply for variations for CMC changes, labeling updates, SPC updates and renewals
    3. How to analyze and evaluate regulatory concerns and risks in life cycle management using relevant regulations, guidelines and best practices in order to maintain regulatory compliance
    4. How to advise and decide on the optimal regulatory strategies for life cycle management projects

    What your company will get

    1. A regulatory professional who understands the basic regulatory requirements for a pharmaceutical product in the post-approval phase and the regulations concerning pediatrics, risk management plans, referrals and generics
    2. A regulatory professional who knows how and when to apply for variations
    3. A regulatory affairs professional who is able to analyze and evaluate regulatory concerns and risks in life cycle management and knows how to be regulatory compliant
    4. A regulatory affairs professional who is able to advise and decide on the optimal regulatory strategies for life cycle management projects

    Course information

    Literature

    Prior to the course you will get access to mandatory and optional readings via your personal Atrium log-in.

    Please familiarize yourself with the mandatory readings before starting the course.

    The mandatory readings are also part of the examination syllabus.

    Prerequisites

    To enroll in this course, you must have a relevant educational background at bachelor level and experience in regulatory affairs or other equivalent qualifications. We consider all applications upon registration.

    If you do not fulfill the requirements, you can still apply for the course if you have experience in the pharmaceutical/biological area that would allow you to benefit from the training and enable you to participate actively during the module. Up to 10% of the positions on our course are filled by applicants who have no or limited experience in regulatory affairs.

    We consider applicants on a case-by-case basis.

    Examination

    The exam is held online, usually 4-6 weeks after the course.

    You will receive a link with exam questions via your personal Atrium log-in.

    In order to participate in the exam, you must have attended the course.

    This course is a part of a diploma

    Diploma in Regulatory Affairs

    The regulatory affairs diploma gives you an understanding of the entire regulatory affairs platform of the medicinal lifecycle. All courses have been designed in collaboration with highly acclaimed experts that are on our regulatory affairs Advisory Board.

    Read more

    Course leaders

    Christina Balslev Rindshøj
    VP, Head of Regulatory Affairs
    Zealand Pharma A/S
    Dorte Bjørn-Larsen
    Global Regulatory Lead, RA Rare Endocrine Disorders
    Novo Nordisk A/S

    Lecturers

    Anna Silke Hammerbacher
    Senior Director & Global Regulatory Lead
    Daiichi Sankyo
    Sofia Persdotter
    Global Regulatory Affairs CMC Lead
    Ferring Pharmaceuticals A/S
    Mette Due Theilade Thomsen
    Managing Director
    PIP Adviser
    Mette Stie Kallesøe
    Head of Pharmacovigilance QPPV
    Hansa Biopharma AB
    Samuel David Ramsden
    Head of Risk Management Office
    Boehringer Ingelheim Pharma GmbH & Co. KG
    Lilia Nicolaeva Lisdorf
    Senior Principal Regulatory Specialist
    ALK
    Hanne Brokopp
    NDA Principal Consultant
    NDA Group, Luxembourg
    Ingrid Prieschl
    Regulatory Consultant
    Zwiers Regulatory Consultancy BV
    Lars Sparre Conrad
    PhD, European Patent Attorney, Chief Patent Specialist, Corporate Patents & Trademarks
    H. Lundbeck A/S
    Samantha Donslund Schwab
    Associate Director
    Novo Nordisk A/S
    Jacob Larsen
    Scientific Director
    Novo Nordisk A/S

    You may also be interested in these courses

    Want to know more or need help?

    Contact Client Manager Mette Ribergaard Rasmussen at +45 39 15 09 30

    Send me a message